Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease
Authors:
- Christoph BickelCBChristoph Bickel
- the AtheroGene Study InvestigatorsTIthe AtheroGene Study Investigators
- 1 January 2011
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 75 (5) , 1184-1191
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 34 references indexed in Scilit:
- Procalcitonin as a prognostic marker in patients with acute myocardial infarctionBiomarkers, 2010
- Elevated Serum C-Reactive Protein Levels Predict Cardiovascular Events in the Japanese Coronary Artery Disease (JCAD) StudyCirculation Journal, 2009
- C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart StudyCirculation: Cardiovascular Quality and Outcomes, 2008
- Procalcitonin in acute myocardial infarctionAcute Cardiac Care, 2008
- Procalcitonin in patients with acute coronary syndromeActa Cardiologica, 2007
- Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene studyEuropean Heart Journal, 2006
- The potential role of procalcitonin in the emergency department management of febrile young adults during a sustained meningococcal epidemicEmergency Medicine Australasia, 2004
- CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levelsThrombosis and Haemostasis, 2004
- Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cellsCritical Care Medicine, 2002
- Outcome Prediction by Traditional and New Markers of Inflammation in Patients with SepsisClinical Chemistry and Laboratory Medicine (CCLM), 1999